139 results on '"Reichart B"'
Search Results
2. Influence of Polyclonal Antithymocyte Globulins on the Expression of Adhesion Molecules of Isolated Human Umbilical Vein Endothelial Cells
3. Multidrug-Resistant Gram-Positive Infections in Patients With Ventricular Assist Devices: The Role of Daptomycin
4. Antithymocyte Globulins Bind to Human Umbilical Vein Endothelial Cells
5. Clinical Heart Transplantation With Extended Preservation Time (>5 Hours): Experience With University of Wisconsin Solution
6. Combination of hDAF-transgenic pig hearts and immunoadsorption in heterotopic xenotransplantation of immunosuppressed baboons
7. Mean xenograft survival of 14.6 days in a small group of hDAF-transgenic pig hearts transplanted orthotopically into baboons
8. Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?
9. The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels
10. Myocardial nitric oxide synthase gene-expression and endothelial function in chronic rejection after cardiac transplantation
11. Primary Graft Failure and Ca 2+ Sensitizers After Heart Transplantation
12. Transgenic Animals in Experimental Xenotransplantation Models: Orthotopic Heart Transplantation in the Pig-to-Baboon Model
13. Fluvastatin as Co-Medication in Heart Transplant Recipients With Elevated Creatine-Kinase
14. AAV-Mediated Gene Transfer to Cardiac Cells in a Heterotopic Rat Heart Transplantation Model
15. Fluorescent Microspheres Reveal Different Regional Blood Flow in Hyperacutely Rejected Nontransgenic and hDAF Pig Hearts
16. Combining the hDAF transgene with the GP IIb/IIIa inhibitor tirofiban improves heart performance and reduces myocardial damage following hyperacute rejection in an ex vivo perfusion model
17. Lack of impact of donor sodium levels on outcome after heart transplantation
18. Incidence and spectrum of infections in lung transplanted patients: comparison of four different immunosuppressive protocols
19. Technique of immunoapheresis in heterotopic and orthotopic xenotransplantation of pig hearts into cynomolgus and rhesus monkeys
20. Tacrolimus-based immunosuppressive protocols in lung transplantation
21. Myocardial preservation in clinical cardiac transplantation
22. Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine a
23. Assessment of intraindividual variability of coronary flow reserve in angiographically normal coronary arteries in transplant recipients: a study with intracoronary doppler and intravascular ultrasound
24. Pharmacokinetics of Tacrolimus (FK506) in Primary Orthotopic Heart Transplant Patients
25. Effects of Tacrolimus and Cyclosporine on the Coronary Microcirculation After Heart Transplantation: A Prospective Study With Serial Intracoronary Flow Measurements
26. Diagnosis of Acute Rejection With Cardiac Ultrasound
27. Role of Dobutamine Stress Echocardiography for Diagnosis of Cardiac Allograft Vasculopathy
28. Cytoimmunology in Monitoring: the Munich Experience
29. Tacrolimus (FK506) proves superior to OKT3 for treating episodes of persistent rejection following intrathoracic transplantation
30. Procalcitonin: a new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation.
31. Human decay accelerating factor successfully protects pig hearts from hyperacute rejection by human blood.
32. Is a reduction of graft vessel disease by maximal treatment of hypercholesterolemia after heart transplantation possible?
33. The role of PTCA in the management of focal critical lesions in transplant coronary artery disease.
34. Cardiac changes during acute allograft rejection: evaluation by serial echocardiographic measurements over a 5-year follow-up period.
35. First experience with FK 506 for treatment of chronic pulmonary rejection.
36. Heparin-induced extracorporeal low-density-lipoprotein plasmapheresis (HELP) and its use in heart transplant patients with severe hypercholesterolemia.
37. Enhanced endothelin-1 urine excretion in patients with graft arteriosclerosis after heart transplantation.
38. New trends in clinical immunosuppression.
39. Changes of resorption and metabolism of cyclosporine after heart transplantation by the influence of gastrointestinal agents.
40. Antimyosin scintigraphy after orthotopic heart transplantation in children.
41. Pulmonary rejection diagnosis after lung and heart-lung transplantation.
42. University of Wisconsin solution for myocardial protection in heart transplantation--a comparison with HTK.
43. Modern application for an old compound: 8-methoxypsoralen for photochemotherapy after heart transplantation.
44. Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model.
45. Selection and chimerization of a monoclonal CD4 antibody for heart transplantation.
46. Focal rejection: a cause of false-negative biopsy results?
47. Endothelialization of aldehyde-fixed cardiac valve bioprostheses.
48. Retransplantation of an already transplanted heart.
49. Treatment of hypercholesterolemia and prevention of coronary artery disease after heart transplantation by combination of low-dose simvastatin and HELP-LDL-apheresis.
50. Continuous infusion of angiopeptin significantly reduces accelerated graft vessel disease induced by FK 506 in a rat heart allograft model.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.